Literature DB >> 8836126

Aging of phosphylated human acetylcholinesterase: catalytic processes mediated by aromatic and polar residues of the active centre.

A Shafferman1, A Ordentlich, D Barak, D Stein, N Ariel, B Velan.   

Abstract

We have examined the effects of 11 substitutions of active centre gorge residues of human acetylcholinesterase (HuAChE) on the rates of phosphonylation by 1,2,2-trimethylpropyl methyl-phosphonofluoridate (soman) and the aging of the resulting conjugates. The rates of phosphonylation were reduced to as little as one-seventieth, mainly in mutants of the hydrogen-bond network (Glu-202, Glu-450, Tyr-133). These recombinant enzymes as well as the F338A, W86A, W86F and D74N mutant HuAChEs varied in their resistance to aging (15-3300-fold relative to the wild type). The most dramatic resistance to aging was observed for the phosphonyl conjugate of the mutant W86A enzyme (1850-3300-fold relative to the wild type). It is proposed that Trp-86 contributes to the aging process by stabilizing the evolving carbonium ion on the 1,2,2-trimethylpropyl moiety, via charge-pi interaction. The rate-enhancing effect of Trp-86 provides a rationale for the unique facility of aging in soman-inhibited cholinesterases, compared with the corresponding conjugates in other serine hydrolases. Replacements of Glu-202 by aspartic acid, glutamine or alanine residues resulted in a similar (1/130-1/300) decrease of the rates of aging. A comparable decrease was also observed for the conjugate of the F338A mutant. These results, and the similar pH dependence of aging rates for the wild-type and E202Q and F338A mutant HuAChEs, indicate that Glu-202 is not involved in proton transfer to the phosphonyl moiety. On the basis of these findings and of molecular modelling we suggest that Glu-202 and Phe-338 contribute to the aging process by stabilizing the imidazolium of the catalytic triad His-447 via charge-charge and charge-pi interactions respectively, thereby facilitating an oxonium formation on the phosphonyl moiety.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836126      PMCID: PMC1217693          DOI: 10.1042/bj3180833

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Aged and non-aged pyrenebutyl-containing organophosphoryl conjugates of chymotrypsin. Preparation and comparison by 31P-NMR spectroscopy.

Authors:  J Grunwald; Y Segall; E Shirin; D Waysbort; N Steinberg; I Silman; Y Ashani
Journal:  Biochem Pharmacol       Date:  1989-10-01       Impact factor: 5.858

2.  Engineering resistance to 'aging' of phosphylated human acetylcholinesterase. Role of hydrogen bond network in the active center.

Authors:  A Ordentlich; C Kronman; D Barak; D Stein; N Ariel; D Marcus; B Velan; A Shafferman
Journal:  FEBS Lett       Date:  1993-11-15       Impact factor: 4.124

3.  Mutagenesis of essential functional residues in acetylcholinesterase.

Authors:  G Gibney; S Camp; M Dionne; K MacPhee-Quigley; P Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

4.  Ageing and dealkylation of Soman (pinacolylmethylphosphonofluoridate)-inactivated eel cholinesterase.

Authors:  H O Michel; B E Hackley; L Berkowitz; G List; E B Hackley; W Gillilan; M Pankau
Journal:  Arch Biochem Biophys       Date:  1967-07       Impact factor: 4.013

5.  Histidine-aromatic interactions in barnase. Elevation of histidine pKa and contribution to protein stability.

Authors:  R Loewenthal; J Sancho; A R Fersht
Journal:  J Mol Biol       Date:  1992-04-05       Impact factor: 5.469

6.  Kinetic, equilibrium, and spectroscopic studies on dealkylation ("aging") of alkyl organophosphonyl acetylcholinesterase. Electrostatic control of enzyme topography.

Authors:  H A Berman; M M Decker
Journal:  J Biol Chem       Date:  1986-08-15       Impact factor: 5.157

7.  Contribution of aromatic moieties of tyrosine 133 and of the anionic subsite tryptophan 86 to catalytic efficiency and allosteric modulation of acetylcholinesterase.

Authors:  A Ordentlich; D Barak; C Kronman; N Ariel; Y Segall; B Velan; A Shafferman
Journal:  J Biol Chem       Date:  1995-02-03       Impact factor: 5.157

8.  Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic activity and in polypeptide folding.

Authors:  A Shafferman; C Kronman; Y Flashner; M Leitner; H Grosfeld; A Ordentlich; Y Gozes; S Cohen; N Ariel; D Barak
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

9.  Stereospecific reactivation of human brain and erythrocyte acetylcholinesterase inhibited by 1,2,2-trimethylpropyl methylphosphonofluoridate (soman).

Authors:  L P de Jong; S P Kossen
Journal:  Biochim Biophys Acta       Date:  1985-08-23

10.  The role of glutamate-199 in the aging of cholinesterase.

Authors:  A Saxena; B P Doctor; D M Maxwell; D E Lenz; Z Radic; P Taylor
Journal:  Biochem Biophys Res Commun       Date:  1993-11-30       Impact factor: 3.575

View more
  32 in total

1.  Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase.

Authors:  P Masson; M T Froment; C F Bartels; O Lockridge
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Catalytic Soman Scavenging by the Y337A/F338A Acetylcholinesterase Mutant Assisted with Novel Site-Directed Aldoximes.

Authors:  Zrinka Kovarik; Nikolina Maček Hrvat; Maja Katalinić; Rakesh K Sit; Alexander Paradyse; Suzana Žunec; Kamil Musilek; Valery V Fokin; Palmer Taylor; Zoran Radić
Journal:  Chem Res Toxicol       Date:  2015-04-16       Impact factor: 3.739

3.  Oxime-assisted acetylcholinesterase catalytic scavengers of organophosphates that resist aging.

Authors:  Rory Cochran; Jaroslaw Kalisiak; Tuba Küçükkilinç; Zoran Radic; Edzna Garcia; Limin Zhang; Kwok-Yiu Ho; Gabriel Amitai; Zrinka Kovarik; Valery V Fokin; K Barry Sharpless; Palmer Taylor
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

4.  Selection of a human butyrylcholinesterase-like antibody single-chain variable fragment resistant to AChE inhibitors from a phage library expressed in E. coli.

Authors:  Adriano Podestà; Serena Rossi; Ilaria Massarelli; Sara Carpi; Barbara Adinolfi; Stefano Fogli; Anna Maria Bianucci; Paola Nieri
Journal:  MAbs       Date:  2014 Jul-Aug       Impact factor: 5.857

5.  Investigating the structural influence of surface mutations on acetylcholinesterase inhibition by organophosphorus compounds and oxime reactivation.

Authors:  Tuba Küçükkilinç; Rory Cochran; Jaroslaw Kalisiak; Edzna Garcia; Anne Valle; Gabi Amitai; Zoran Radić; Palmer Taylor
Journal:  Chem Biol Interact       Date:  2010-04-09       Impact factor: 5.192

Review 6.  Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior.

Authors:  Patrick Masson; Oksana Lockridge
Journal:  Arch Biochem Biophys       Date:  2009-12-11       Impact factor: 4.013

7.  Human carboxylesterase 1 stereoselectively binds the nerve agent cyclosarin and spontaneously hydrolyzes the nerve agent sarin.

Authors:  Andrew C Hemmert; Tamara C Otto; Monika Wierdl; Carol C Edwards; Christopher D Fleming; Mary MacDonald; John R Cashman; Philip M Potter; Douglas M Cerasoli; Matthew R Redinbo
Journal:  Mol Pharmacol       Date:  2010-01-05       Impact factor: 4.436

8.  Identifying unexpected therapeutic targets via chemical-protein interactome.

Authors:  Lun Yang; Jian Chen; Leming Shi; Michael P Hudock; Kejian Wang; Lin He
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

9.  Crystal structures of brain group-VIII phospholipase A2 in nonaged complexes with the organophosphorus nerve agents soman and sarin.

Authors:  Todd M Epstein; Uttamkumar Samanta; Stephen D Kirby; Douglas M Cerasoli; Brian J Bahnson
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

10.  Modulation of circulatory residence of recombinant acetylcholinesterase through biochemical or genetic manipulation of sialylation levels.

Authors:  T Chitlaru; C Kronman; M Zeevi; M Kam; A Harel; A Ordentlich; B Velan; A Shafferman
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.